Metrics to compare | 300723 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300723PeersSector | |
|---|---|---|---|---|
P/E Ratio | 89.1x | −6.8x | −0.4x | |
PEG Ratio | 0.66 | 0.04 | 0.00 | |
Price/Book | 9.2x | 1.9x | 2.6x | |
Price / LTM Sales | 19.0x | 2.9x | 3.0x | |
Upside (Analyst Target) | −9.7% | 45.1% | 51.7% | |
Fair Value Upside | Unlock | 0.8% | 8.8% | Unlock |
ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services. The company was formerly known as ApicHope Pharmaceutical Co., Ltd and changed its name to ApicHope Pharmaceutical Group Co., Ltd. in December 2024. ApicHope Pharmaceutical Group Co., Ltd. was founded in 2002 and is headquartered in Guangzhou, China.